Login or sign up
For business

Cascade Prodrug

3.9· 8 reviews
Average ratingAverage
3.9/ 5

Based on 8 reviews

525%
438%
338%
20%
10%
Ask AI

Ask AI about Cascade Prodrug

Generated with AI from 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Tonya Whitaker
Reviews 1

Cascade Prodrug is a really great company to work with. Their products are top-notch and their customer service is excellent. I've been using their services for over a year now and I've always been impressed with the quality and reliability. Keep up the good work!

Fred Hatfield
Reviews 1

I've been using Cascade Prodrug's services for quite some time now and I must say that I'm really impressed. They offer a wide range of high-quality products and their customer service is top-notch. I would definitely recommend them to anyone in need of their services.

Ashley Epes
Reviews 1

I recently came across a company that offers fantastic products and exceptional services. Their website, cascadingprodrug.com, provides detailed information about their offerings and makes it easy to place orders. I have been a satisfied customer for several months now. Highly recommended!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Cascade Prodrug

Cascade Prodrug is a revitalized pharmaceutical company developing targeted prodrug therapies for the treatment of hyper-proliferative diseases. The lead drug candidates in the development pipeline are prodrug derivatives of vinca alkaloid compositions with promising activity for treating hyper-proliferative disorders. Further, the compounds are being tested as stand-alone pharmaceuticals or in combination with one or more other active agents or treatments, to treat hyper-proliferative disorders. The Company’s initial disease focus is on a pipeline of prodrugs that are activated in abnormally low oxygen concentrations found in most solid tumors (tumor hypoxia). By selectively targeting tumor hypoxia for activation, the Company’s prodrugs are less toxic to normal cells thereby providing a safer more effective cancer treatment.

The company was founded in 2009 and is based in Eugene, Oregon.